Intermittent parathyroid hormone 1-34 induces oxidation and deterioration of mineral and collagen quality in newly formed mandibular bone

被引:6
|
作者
Yoshioka, Yohsuke [1 ]
Yamachika, Eiki [2 ]
Nakanishi, Makoto [3 ]
Ninomiya, Tadashi [4 ]
Akashi, Sho [1 ]
Kondo, Sei [1 ]
Moritani, Norifumi [1 ]
Kobayashi, Yasuhiro [5 ]
Fujii, Tatsuo [3 ]
Iida, Seiji [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan
[2] Okayama Univ Hosp, Dept Oral & Maxillofacial Reconstruct Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan
[3] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Appl Chem, Kita Ku, 1-1-1 Tsushima Naka, Okayama, Japan
[4] Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo, Japan
[5] Matsumoto Dent Univ, Inst Oral Sci, Div Hard Tissue Res, 1780 Gobara Hirooka, Nagano, Japan
关键词
OSTEOPOROSIS; MECHANISMS; INCREASES; MELATONIN; STRENGTH; IMPLANTS; THERAPY;
D O I
10.1038/s41598-019-44389-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intermittent parathyroid hormone (PTH) administration is known to promote bone healing after surgical procedures. However, the mechanism and influence of PTH on the mineral and collagen quality of the jaw are not well understood. Most studies have focused on analyzing the bone density and microstructure of the mandible, and have insufficiently investigated its mineral and collagen quality. Oxidative stress activates osteoclasts, produces advanced glycation end products, and worsens mineral and collagen quality. We hypothesized that PTH induces oxidation and affects the mineral and collagen quality of newly formed mandibular bone. To test this, we examined the mineral and collagen quality of newly formed mandibular bone in rats administered PTH, and analyzed serum after intermittent PTH administration to examine the degree of oxidation. PTH administration reduced mineralization and worsened mineral and collagen quality in newly formed bone. In addition, total anti-oxidant capacity in serum was significantly decreased and the oxidative-INDEX was increased among PTH-treated compared to vehicle-treated rats, indicating serum oxidation. In conclusion, intermittent administration of PTH reduced mineral and collagen quality in newly formed mandibular bone. This effect may have been induced by oxidation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The effect of bisphosphonate and intermittent human parathyroid hormone 1-34 treatments on cortical bone allografts in rabbits
    Yamamoto, Y.
    Washimi, Y.
    Kanaji, A.
    Tajima, K.
    Ishimura, D.
    Yamada, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (02) : 139 - 145
  • [2] The effectiveness of intermittent rat parathyroid hormone (1-34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats
    Montero, M.
    Serfati, D.
    Luna, S.
    Diaz-Curiel, M.
    Carrascal, M. T.
    Gomez, S.
    De la Piedra, C.
    AGING MALE, 2010, 13 (01): : 59 - 73
  • [3] Intermittent weekly administration of human parathyroid hormone (1-34) improves bone-hydroxyapatite block bonding in ovariectomized rats
    Kamo, Keiji
    Miyakoshi, Naohisa
    Kasukawa, Yuji
    Nozaka, Koji
    Sasaki, Hiroshi
    Shimada, Yoichi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (06) : 634 - 640
  • [4] Optimal timing for intermittent administration of parathyroid hormone (1-34) for distraction osteogenesis in rabbits
    Inada, Narisaku
    Ohata, Tetsuya
    Maruno, Hideto
    Morii, Takeshi
    Hosogane, Naobumi
    Ichimura, Shoichi
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2022, 17 (01)
  • [5] Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure
    Gafni, Rachel I.
    Brahim, Jaime S.
    Andreopoulou, Panagiota
    Bhattacharyya, Nisan
    Kelly, Marilyn H.
    Brillante, Beth A.
    Reynolds, James C.
    Zhou, Hua
    Dempster, David W.
    Collins, Michael T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (08) : 1811 - 1820
  • [6] Combined antisclerostin antibody and parathyroid hormone (1-34) synergistically enhance the healing of bone defects in ovariectomized rats
    Lin, Jinti
    Wu, Jun
    Sun, Shuaibo
    Chen, Kai
    Wu, Hongqiang
    Lin, Renjin
    Zhou, Chengwei
    Kong, Jianzhong
    Zhou, Kailiang
    Shui, Xiaolong
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2020, 53 (02): : 163 - 170
  • [7] Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice
    Alexander, JM
    Bab, I
    Fish, S
    Müller, R
    Uchiyama, T
    Gronowicz, G
    Nahounou, M
    Zhao, Q
    White, DW
    Chorev, M
    Gazit, D
    Rosenblatt, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (09) : 1665 - 1673
  • [8] Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion
    Morimoto, Tokimitsu
    Kaito, Takashi
    Kashii, Masafumi
    Matsuo, Yohei
    Sugiura, Tsuyoshi
    Iwasaki, Motoki
    Yoshikawa, Hideki
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2014, 96A (13): : e107(1)
  • [9] Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats
    McManus, Julie F.
    Davey, Rachel A.
    MacLean, Helen E.
    Doust, Elizabeth A.
    Chiu, W. S. Maria
    Sims, Natalie A.
    Bouxsein, Mary L.
    Glatt, Vaida
    Zajac, Jeffrey D.
    Danks, Janine A.
    BONE, 2008, 42 (06) : 1164 - 1174
  • [10] The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats
    Wu, Jian
    Cai, Xian-Hua
    Qin, Xing-Xing
    Liu, Yan-Xi
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2018, 51 (05): : 550 - 556